ArticleOncoimmunology

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.

Todd A Braciak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.